Shanghai Sharks faced a doping breach when former NBA center Hassan Whiteside tested positive for prohibited substances on May 6, 2025, triggering the CBA's zero‑tolerance policy. The club immediately activated its internal response and began cooperating with the China Anti‑Doping Agency (CHINADA).
What happened?
During the opening game of the 2025‑26 playoffs against Shandong on May 6, Whiteside was tested in‑competition. CHINADA later announced that his sample contained metabolites of oxandrolone and clomifene. Whiteside waived his right to have the B sample analyzed. The CBA said it would impose strict sanctions once the final determination is issued.
How does it affect Shanghai Sharks?
Even after the violation, Whiteside played in five more games, including all four semifinal matches, helping Shanghai beat Beijing and reach the finals. He did not appear in the championship series against Zhejiang, where Shanghai won the title 4‑1, securing its second league crown. His absence reduced interior defense, rebounding, and rim‑protection.
How is the CBA enforcing zero‑tolerance?
The CBA pledged to follow the Anti‑Doping Regulations and league rules to punish the player, the club, and any staff involved. It also announced league‑wide anti‑doping education to raise red‑line awareness and prevent future breaches, aiming to protect a fair, just, and healthy competitive environment.
What’s next for Shanghai Sharks?
Management said a thorough internal review will be completed to ensure all athletes comply with anti‑doping rules. Coaches plan to incorporate drug‑risk education into practice and conduct full‑team testing before the next season. The club is also scouting for a new interior presence with strong rebounding and shot‑blocking to fill the void left by Whiteside.
Shanghai Sharks are tightening discipline while striving to stay competitive and set a positive example for the CBA.